Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making
出版年份 2022 全文链接
标题
Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making
作者
关键词
-
出版物
PHARMACEUTICAL RESEARCH
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-13
DOI
10.1007/s11095-022-03288-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder
- (2021) Shamir N. Kalaria et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model
- (2021) Anna Mueller-Schoell et al. Cancers
- Model‐Informed Drug Development Approaches to Assist New Drug Development in the COVID‐19 Pandemic
- (2021) Ye Xiong et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical development times for innovative drugs
- (2021) Dean G. Brown et al. NATURE REVIEWS DRUG DISCOVERY
- Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration
- (2021) Jane P. F. Bai et al. CPT-Pharmacometrics & Systems Pharmacology
- Application of Machine Learning in Drug Development and Regulation: Current Status and Future Potential
- (2020) Qi Liu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
- (2020) Olivier J. Wouters et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients
- (2020) Jianghong Fan et al. CLINICAL INFECTIOUS DISEASES
- Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications
- (2020) Islam R. Younis et al. JAMA Psychiatry
- Association of genetic mutations and loss of ambulation in childhood‐onset dystrophinopathy
- (2020) Gregory Haber et al. MUSCLE & NERVE
- The US Food and Drug Administration's Model‐Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact
- (2019) Rajanikanth Madabushi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory Perspective
- (2019) Youwei Bi et al. AAPS Journal
- Model‐Informed Drug Development: A Regulatory Perspective on Progress
- (2019) Hao Zhu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling
- (2019) Youwei Bi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Model-Informed Drug Development and Review for Generic Products: Summary of FDA Public Workshop
- (2018) Lanyan Fang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Generating Model Integrated Evidence for Generic Drug Development and Assessment
- (2018) Liang Zhao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs
- (2015) Jens Markus Borghardt et al. AAPS Journal
- Novel bioequivalence approach for narrow therapeutic index drugs
- (2015) LX Yu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Quantifying T lymphocyte turnover
- (2013) Rob J. De Boer et al. JOURNAL OF THEORETICAL BIOLOGY
- Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions
- (2011) Joo Yeon Lee et al. CLINICAL PHARMACOKINETICS
- Clarification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic Studies
- (2011) Yaning Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Elucidation of Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug Development
- (2009) Y Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Leveraging Prior Quantitative Knowledge to Guide Drug Development Decisions and Regulatory Science Recommendations: Impact of FDA Pharmacometrics During 2004-2006
- (2008) Yaning Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now